Biochemical and histological effects of embryonic stem cells in a mouse model of renal failure

Gustavo Jesus Vazquez-Zapien1, Adriana Martinez-Cuazitl, Laura Susana Rangel-Cova

  • 1Laboratorio de Biología Celular y Tisular, Escuela Militar de Medicina, Centro Militar de Ciencias de la Salud, Secretaría de la Defensa Nacional, Ciudad de México, México; mmcmaribel@gmail.com.

Insights

Mouse embryonic stem cell (mESC) implantation in mice with induced renal failure (RF) significantly reduced mortality and prevented severe kidney damage. This study highlights the regenerative potential of mESC in treating kidney disease.

Area of Science:

  • Nephrology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Kidney diseases represent a significant global health burden, leading to complications and reduced quality of life.
  • Stem cells exhibit differentiation capabilities and have shown promise in animal models of disease.
  • Current renal failure (RF) treatments have limitations, necessitating exploration of novel therapeutic approaches.

Purpose of the Study:

  • To investigate the therapeutic effects of mouse embryonic stem cell (mESC) transplantation in a murine model of long-term renal failure (RF).
  • To evaluate the biochemical and histological outcomes following mESC implantation in mice with cisplatin-induced RF.

Main Methods:

  • Long-term RF was induced in mice using cisplatin.
  • Mice received intraperitoneal injections of either saline (control) or 50,000 mESC at 24 hours, 7 days, and 13 days post-renal failure induction (RFI).
  • Serum biochemical analysis, mortality rates, and histopathological examinations of renal tissues (tubular system and glomeruli) were performed.

Main Results:

  • Both groups exhibited elevated blood urea nitrogen (BUN) and creatinine levels three days post-RFI.
  • The mESC-treated group showed significantly lower accumulated mortality compared to the control group.
  • Histopathological analysis revealed tubular dilatation, glomerulosclerosis, and collapsed glomeruli in controls, whereas the mESC group displayed regenerative signs without glomerulosclerosis or collapsed glomeruli.

Conclusions:

  • Implantation of mESC in mice with induced RF significantly reduced mortality rates.
  • mESC treatment effectively mitigated severe histological deterioration, including glomerulosclerosis and tubular damage.
  • These findings suggest that mESC holds therapeutic potential for mitigating the progression of kidney disease.

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.8K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
443
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
Stomach Histology01:26

Stomach Histology

The stomach comprises several layers that work together to facilitate digestion and protect the organ. The outermost layer is called the serosa, which provides support and protection to the stomach. The muscularis externa layer is responsible for the mechanical breakdown of food by contracting and moving the stomach. The submucosa layer, located beneath the muscularis externa, contains connective tissue, blood vessels, nerves, and glands that secrete mucus and other substances essential for...
3.0K